Correlation Between Kazia Therapeutics and Cytokinetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kazia Therapeutics and Cytokinetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kazia Therapeutics and Cytokinetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kazia Therapeutics and Cytokinetics, you can compare the effects of market volatilities on Kazia Therapeutics and Cytokinetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kazia Therapeutics with a short position of Cytokinetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kazia Therapeutics and Cytokinetics.

Diversification Opportunities for Kazia Therapeutics and Cytokinetics

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Kazia and Cytokinetics is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Kazia Therapeutics Ltd and Cytokinetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytokinetics and Kazia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kazia Therapeutics are associated (or correlated) with Cytokinetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytokinetics has no effect on the direction of Kazia Therapeutics i.e., Kazia Therapeutics and Cytokinetics go up and down completely randomly.

Pair Corralation between Kazia Therapeutics and Cytokinetics

Given the investment horizon of 90 days Kazia Therapeutics is expected to under-perform the Cytokinetics. In addition to that, Kazia Therapeutics is 1.78 times more volatile than Cytokinetics. It trades about -0.21 of its total potential returns per unit of risk. Cytokinetics is currently generating about 0.01 per unit of volatility. If you would invest  4,917  in Cytokinetics on July 8, 2022 and sell it today you would lose (16.00)  from holding Cytokinetics or give up 0.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kazia Therapeutics Ltd  vs.  Cytokinetics

 Performance (%) 
       Timeline  
Kazia Therapeutics 
Kazia Performance
0 of 100
Over the last 90 days Kazia Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Kazia Price Channel

Cytokinetics 
Cytokinetics Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Cytokinetics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Cytokinetics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Cytokinetics Price Channel

Kazia Therapeutics and Cytokinetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kazia Therapeutics and Cytokinetics

The main advantage of trading using opposite Kazia Therapeutics and Cytokinetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kazia Therapeutics position performs unexpectedly, Cytokinetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will offset losses from the drop in Cytokinetics' long position.
Kazia Therapeutics vs. Yougov Plc
Kazia Therapeutics vs. Hakuhodo Dy Holdings
Kazia Therapeutics vs. Cyberagent Inc ADR
Kazia Therapeutics vs. Xunlei Limited
The idea behind Kazia Therapeutics and Cytokinetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Cytokinetics vs. Bio-Rad Laboratories
Cytokinetics vs. Intuitive Surg
Cytokinetics vs. Bristol-Myers Squibb
Cytokinetics vs. Eli Lilly And
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go